Tekla Capital Management’s Bio-Techne TECH Stock Holding History

Tekla Capital Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-21,600	Closed	-$2.62M	–	180
2021 Q3	$2.62M	Sell	21,600 -8,800	-29%	-$1.07M	0.08%	128
2021 Q2	$3.42M	Hold	30,400	–	–	0.11%	135
2021 Q1	$2.9M	Sell	30,400 -176,440	-85%	-$16.1M	0.1%	150
2020 Q4	$16.4M	Hold	206,840	–	–	0.58%	50
2020 Q3	$12.8M	Hold	206,840	–	–	0.48%	55
2020 Q2	$13.7M	Sell	206,840 -23,924	-10%	-$1.43M	0.52%	44
2020 Q1	$10.9M	Buy	230,764 +30,400	+15%	+$1.52M	0.49%	43
2019 Q4	$11M	Buy	200,364 +78,216	+64%	+$4.1M	0.42%	54
2019 Q3	$5.97M	Buy	122,148 +35,344	+41%	+$1.77M	0.26%	70
2019 Q2	$4.52M	Hold	86,804	–	–	0.18%	93
2019 Q1	$4.31M	Buy	+86,804	New	+$3.91M	0.18%	100

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Tekla Capital Management's TECH Position: Q4 2021 in Review

Tekla Capital Management sold out of Bio-Techne (TECH) in Q4 2021, closing a stake of 21,600 shares — an estimated $2.62M sold.

Tekla Capital Management first reported a position in TECH in Q1 2019 and held it in 11 quarters. The position peaked at $16.4M in Q4 2020. 576 funds tracked by Wall St. Rank hold TECH as of Q4 2021.

Tekla Capital Management reported no remaining Bio-Techne position as of Q4 2021 after selling out during the quarter.
Tekla Capital Management sold 21,600 Bio-Techne shares in Q4 2021, an estimated $2.62M.
Tekla Capital Management first reported a position in Bio-Techne in Q1 2019 and held it in 11 quarters.
Tekla Capital Management's Bio-Techne position peaked at $16.4M in Q4 2020.
576 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2021.

Based on Tekla Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.